HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SRTA

Strata Critical Medical, Inc. (NASDAQ)

Healthcare — Medical Care Facilities

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Strong Buy 1.0 / 5 4 analysts
$5.34
+$0.06 (+1.23%)
Target: $9.25 (73.1%)
Sign in to add SRTA to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$462.48M
P/E Ratio (TTM)-
Forward P/E-
EPS (TTM)$-0.19
Dividend Yield-
Profit Margin20.56%
Revenue Growth87.40%
ROE-6.35%
Debt/Equity1.56
Recommendation Strong Buy 1.0
Analyst Target$9.25
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)45.4
Beta2.20
SMA 20-
SMA 40-
52-Week High$6.50
52-Week Low$3.68
50-Day Avg$5.52
200-Day Avg$4.99
Avg Volume$1.07M
Volume55.2K

Performance Analysis

BULLISH

SRTA shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 59% of its 52-week range.
~ RSI at 45.4 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+ Strong revenue growth of 87.4% year-over-year.
+ Healthy profit margin of 20.6%.
+ Wall Street consensus is "Strong Buy" from 4 analysts.
+ Average analyst target of $9.25 implies 73.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:32 UTC

Back to Screener Export Report